George M. Milne Jr., Director at Amylyx Pharmaceuticals, Inc. (AMLX), sold 70,000 shares at $31.86 ($2.2M) on 2023-03-16, disclosed to the SEC on 2023-03-20.
Open-market sale of $2.2M AMLX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.86 | 33,084 | $1.1M | 47.2% |
| 2 | $31.86 | 33,084 | $1.1M | 47.2% |
| 3 | $32.45 | 1,916 | $62K | 2.8% |
| 4 | $32.45 | 1,916 | $62K | 2.8% |
| Total | $31.89 avg | 70,000 | $2.2M | 100% |
| Filing → |
| AUPH | BUY | 2022-03-08 | $54K | — | Filing → |
| AMLX | BUY | 2022-01-10 | $500K | — | Filing → |
| AUPH | BUY | 2021-03-09 | $65K | — | Filing → |